TNF Inhibitors Linked to Increased Multiple Sclerosis Risk

In a large, retrospective cohort study, investigators found a slightly increased risk for MS in patients on TNF therapy, especially among those being treated for rheumatic disease.
Medscape Medical News

source https://www.medscape.com/viewarticle/983767?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?